RUA Life Sciences (LON:RUA) Stock Price Down 2.8% – Here’s Why

Shares of RUA Life Sciences plc (LON:RUA) fell 2.8% during trading on Friday . The company traded as low as GBX 13.13 and last traded at GBX 13.13. 180 shares changed hands during mid-day trading, a decline of 100% from the average session volume of 208,344 shares. The stock had previously closed at GBX 13.50.

RUA Life Sciences Price Performance

The stock has a market capitalization of £8.15 million, a PE ratio of -2.61 and a beta of 1.21. The firm’s fifty day moving average price is GBX 13.78 and its two-hundred day moving average price is GBX 12.32. The company has a quick ratio of 7.32, a current ratio of 9.01 and a debt-to-equity ratio of 5.42.

RUA Life Sciences (LON:RUA) last posted its earnings results on Friday, January 30th. The company reported GBX (0.23) EPS for the quarter. RUA Life Sciences had a negative return on equity of 26.38% and a negative net margin of 65.72%.

About RUA Life Sciences

The RUA Life Sciences group was created in April 2020 when AorTech International plc acquired RUA Medical Devices Ltd to create a fully formed medical device business. RUA Life Sciences is the holding company of the group trading through four businesses all exploiting the group’s polymer technology. Our vision is to improve the lives of millions of patients by improving and enabling medical devices with Elast-EonTM, the worlds leading long term implantable polyurethane.